[go: up one dir, main page]

NO20053203L - Kombinasjon av lokale esteranestetika. - Google Patents

Kombinasjon av lokale esteranestetika.

Info

Publication number
NO20053203L
NO20053203L NO20053203A NO20053203A NO20053203L NO 20053203 L NO20053203 L NO 20053203L NO 20053203 A NO20053203 A NO 20053203A NO 20053203 A NO20053203 A NO 20053203A NO 20053203 L NO20053203 L NO 20053203L
Authority
NO
Norway
Prior art keywords
combination
ester anesthetics
action
analgesia
onset
Prior art date
Application number
NO20053203A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053203D0 (no
Inventor
Steven L Shafer
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of NO20053203D0 publication Critical patent/NO20053203D0/no
Publication of NO20053203L publication Critical patent/NO20053203L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20053203A 2002-12-20 2005-06-30 Kombinasjon av lokale esteranestetika. NO20053203L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32731002A 2002-12-20 2002-12-20
PCT/US2003/041219 WO2004058329A2 (fr) 2002-12-20 2003-12-18 Anesthesique local a base d'une combinaison d'ester

Publications (2)

Publication Number Publication Date
NO20053203D0 NO20053203D0 (no) 2005-06-30
NO20053203L true NO20053203L (no) 2005-09-19

Family

ID=32680753

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053203A NO20053203L (no) 2002-12-20 2005-06-30 Kombinasjon av lokale esteranestetika.

Country Status (10)

Country Link
EP (1) EP1572218A4 (fr)
JP (1) JP2006513224A (fr)
KR (1) KR20050085736A (fr)
CN (1) CN1729004A (fr)
AU (1) AU2003299885A1 (fr)
BR (1) BR0317519A (fr)
CA (1) CA2507511A1 (fr)
MX (1) MXPA05006771A (fr)
NO (1) NO20053203L (fr)
WO (1) WO2004058329A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060062836A1 (en) * 2004-09-21 2006-03-23 Carter Stephen G Methods of device-assisted drug delivery
ES2585654T3 (es) 2005-03-15 2016-10-07 Animal Ethics Pty Ltd Composición anestésica tópica
ITMI20051633A1 (it) * 2005-09-06 2007-03-07 Sint Sa Nuovo uso di una composizione comprendente cloroprocaina hcl nuova composizione comprendente cloroprocaina hcl e metodo per la sua fabbricazione
AU2007275200A1 (en) * 2006-07-19 2008-01-24 Pharmacofore, Inc. Anesthetic compounds
US20080220062A1 (en) * 2006-10-23 2008-09-11 Psivida, Inc. Sustained release of agents for localized pain management
US20110124685A1 (en) * 2008-01-18 2011-05-26 Jenkins Thomas E Anesthetic Compounds
ITMI20122120A1 (it) * 2012-12-12 2014-06-13 Sint Sa Composizione farmaceutica a base di cloroprocaina per la somministrazione intratecale ripetuta
ITCR20130004A1 (it) * 2013-02-05 2014-08-06 Vincenzo Vigna Farmaco salvavita
US10117847B2 (en) * 2015-12-04 2018-11-06 Ventis Pharma Extended duration local anesthetic formulation
DE102016215037B4 (de) 2016-08-11 2024-10-24 Lamello Ag Federvorrichtung und Verbindungsvorrichtung
BR112020003095A2 (pt) * 2017-09-15 2020-08-25 Sintetica S.A. formulações tópicas de cloroprocaína e métodos de utilização dos mesmos
WO2019226599A1 (fr) * 2018-05-22 2019-11-28 Alkalidx, Inc. Diagnostics et traitements de sujets insensibles à un anesthésique
JP6886551B1 (ja) * 2020-11-06 2021-06-16 医療法人祥和会 歯科用の局所麻酔液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
AU7389098A (en) * 1997-05-16 1998-12-08 Brigham And Women's Hospital Local anesthetic formulations
CA2388828A1 (fr) * 1999-10-22 2001-06-14 Transdermatech, Inc. Formulation d'anesthesique topique
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US20020006435A1 (en) * 2000-01-27 2002-01-17 Samuels Paul J. Transdermal anesthetic and vasodilator composition and methods for topical administration

Also Published As

Publication number Publication date
WO2004058329A3 (fr) 2004-12-29
CN1729004A (zh) 2006-02-01
KR20050085736A (ko) 2005-08-29
NO20053203D0 (no) 2005-06-30
EP1572218A4 (fr) 2007-05-16
MXPA05006771A (es) 2005-09-08
EP1572218A2 (fr) 2005-09-14
JP2006513224A (ja) 2006-04-20
AU2003299885A1 (en) 2004-07-22
WO2004058329A2 (fr) 2004-07-15
CA2507511A1 (fr) 2004-07-15
BR0317519A (pt) 2005-11-16

Similar Documents

Publication Publication Date Title
NO20053203L (no) Kombinasjon av lokale esteranestetika.
NO20056252L (no) Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser
DE60322436D1 (de) Verabreichung von capsaicinoiden
CY1116215T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
MXPA05006670A (es) Administracion de capsaicinoides.
NO20073774L (no) Terapeutiske forbindelser for intranasal administrering av ketorolac
NO20065368L (no) Terapeutiske blandinger inneholdende minst et pyrrolobenzodiazepinderivat og fludarabin
WO2008147482A3 (fr) Procédés et compositions pour améliorer les réponses immunitaires
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
CY1107452T1 (el) Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων
NO20056073L (no) Sammensetninger og fremgangsmater til behandling av alvorlig akutt respitatorisk syndrom (SARS)
EP1962843A4 (fr) Utilisation d'inhibiteurs du parp-1
NO20050718L (no) Topikal behandling av hudsykdommer
NO20052999L (no) Ny synergistisk kombinasjon omfattende roflumilast og formoterol
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
ATE250421T1 (de) Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung
NO20053023L (no) Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol
NO20045344L (no) Kombinasjon for behandling av luftveisforstyrrelser
IS8106A (is) Samsetning makrólíðs og staðdeyfingarlyfs til að meðhöndla húðsjúkdóma
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
UA41154A (uk) Лікувальний засіб "гермогран-м" на основі олії з зародків пшениці

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application